SAP Business Analyst Order to Cash (OTC)
Robert Half Technology • Houston, TX • Posted May 02, 2026
About the Role
Description
The SAP OTC Lead is a hands-on role that will provide SAP Functional design leadership and direction as a part of the newly formed SAP Center of Excellence (COE) within the Information Technology organization. This position will help lead the functional / solution architecture and design of a newly implemented SAP S4/Hana system in the area of OTC (Order to Cash) . The person in this position is required to work with the business sales, distribution, warranty and operational teams, the AMS (Application Managed Services) team, as well as the other SAP functional leads in the SAP COE to ensure that the functional design and configuration in the areas of VMS, Material Management, Variant Configuration, Sales and Distribution, Order to Cash, Procure to Pay and Plant maintenance align with SAP best practices and documentation compliance and can support the operational requirements of the business. This SAP Functional Lead will be supporting (from an OTC perspective) a new SA...
The SAP OTC Lead is a hands-on role that will provide SAP Functional design leadership and direction as a part of the newly formed SAP Center of Excellence (COE) within the Information Technology organization. This position will help lead the functional / solution architecture and design of a newly implemented SAP S4/Hana system in the area of OTC (Order to Cash) . The person in this position is required to work with the business sales, distribution, warranty and operational teams, the AMS (Application Managed Services) team, as well as the other SAP functional leads in the SAP COE to ensure that the functional design and configuration in the areas of VMS, Material Management, Variant Configuration, Sales and Distribution, Order to Cash, Procure to Pay and Plant maintenance align with SAP best practices and documentation compliance and can support the operational requirements of the business. This SAP Functional Lead will be supporting (from an OTC perspective) a new SA...